14-day Premium Trial Subscription Sign Up For FreeGet Free

Aurinia Pharmaceuticals Inc Stock Forecast NASDAQ:AUPH

Price Target and Analyst Ratings

Most Recent Rating

On August 19, 2021 "SVB Leerink" gave "" rating for AUPH. The price target was set to $13.06+0.2%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-19 Reiterated by SVB Leerink $13.00 $13.06+0.2%
2021-05-07 Accumulate - Buy Upgraded by Bloom Burton $10.15
2021-05-07 Buy Reiterated by Oppenheimer $10.15
2021-05-07 Outperform Target Lowered by Royal Bank of Canada $10.15 $26.00 → $19.00
2021-05-07 Outperform Target Lowered by Royal Bank of Canada $10.15 $26.00 → $23.00
2021-04-11 Buy Reiterated by SVB Leerink $12.80
2021-02-25 Outperform Target Lowered by Royal Bank of Canada $14.58 $28.00 → $26.00
2021-01-27 Outperform Target Raised by SVB Leerink $16.05 $24.00 → $28.00
2021-01-26 Overweight Target Raised by Cantor Fitzgerald $17.62 $27.00 → $34.00
2021-01-26 Average - Outperform Target Raised by Royal Bank of Canada $17.62 $20.00 → $28.00
2021-01-25 Target Raised by Oppenheimer $18.73 $20.00 → $28.00
2021-01-25 Buy Target Raised by HC Wainwright $18.73 $30.00 → $35.00
2020-12-18 Buy Target Raised by HC Wainwright $13.03 $28.00 → $30.00
2020-12-17 Buy Reiterated by Oppenheimer $12.94 $20.00
2020-11-12 Target Lowered by Cantor Fitzgerald $12.96 $30.00 → $26.00
2020-11-03 Buy Target Lowered by HC Wainwright $13.97 $34.00 → $28.00
2020-11-03 Buy - Accumulate Downgraded by Bloom Burton $13.97
2020-08-13 Buy Reiterated by Royal Bank of Canada $14.17
2020-08-12 Buy Target Raised by HC Wainwright $14.18 $33.00 → $34.00
2020-07-22 Buy Target Raised by HC Wainwright $16.66 $32.00 → $33.00
2020-06-16 Buy Initiated by BTIG Research $15.88 $20.00
2020-05-17 Buy Reiterated by Royal Bank of Canada $17.16 $20.00
2020-05-05 Outperform Initiated by Cowen $17.20
2020-04-20 Buy Reiterated by HC Wainwright $16.49 $32.00

AUPH Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 96.68% during the next 3 months and, with a 90% probability hold a price between $35.40 and $46.68 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-30 $18.19 $21.05 $23.92
2021-10-01 $18.37 $21.24 $24.11
2021-10-04 $18.56 $21.42 $24.29
2021-10-05 $18.74 $21.61 $24.48
2021-10-06 $18.93 $21.79 $24.66
2021-10-07 $19.11 $21.98 $24.85
2021-10-08 $19.30 $22.16 $25.03
2021-10-11 $19.48 $22.35 $25.22
2021-10-12 $19.67 $22.53 $25.40
2021-10-13 $19.85 $22.72 $25.59
2021-10-14 $20.04 $22.90 $25.77
2021-10-15 $20.22 $23.09 $25.96
2021-10-18 $20.41 $23.28 $26.14
2021-10-19 $20.59 $23.46 $26.33
2021-10-20 $20.78 $23.65 $26.51
2021-10-21 $20.96 $23.83 $26.70
2021-10-22 $21.15 $24.02 $26.88
2021-10-25 $21.33 $24.20 $27.07
2021-10-26 $21.52 $24.39 $27.25
2021-10-27 $21.70 $24.57 $27.44
2021-10-28 $21.89 $24.76 $27.62
2021-10-29 $22.07 $24.94 $27.81
2021-11-01 $22.26 $25.13 $27.99
2021-11-02 $22.45 $25.31 $28.18
2021-11-03 $22.63 $25.50 $28.37
2021-11-04 $22.82 $25.68 $28.55
2021-11-05 $23.00 $25.87 $28.74
2021-11-08 $23.19 $26.05 $28.92
2021-11-09 $23.37 $26.24 $29.11
2021-11-10 $23.56 $26.42 $29.29

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a clinical stage pharmaceutical company, engages in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company’s lead drug candidate is Voclosporin, a calcineurin inhibitor, which is in Phase IIb clinical trial for the treatment of lupus nephritis. It has a collaboration agreement with Paladin Labs Inc. to maintain the patent portfolio for Voclosporin in Canada, South Africa, and Israe... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT